𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experience with the early treatment of childhood haemangiomata using the flashlamp-pumped dye laser

✍ Scribed by U. Hohenleutner; W. Bäumler; S. Karrer; S. Michel; M. Landthaler

Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
251 KB
Volume
11
Category
Article
ISSN
0268-8921

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five years' experience of treating port
Five years' experience of treating port wine stains with the flashlamp-pumped pulsed dye laser
✍ G.A. KATUGAMPOLA; S.W. LANIGAN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

During the last 5 years, 640 patients had treatment to their port wine stains (PWS) with a flashlamp-pumped pulsed dye laser. One hundred and fifty-six patients have been discharged for varying reasons, of which 59 (38%) achieved excellent (at least 75%) lightening of their birthmark. Of the remaini

Long-term results in the treatment of ch
Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: An evaluation of 617 cases
✍ Silvia Hohenleutner; Elke Badur-Ganter; Michael Landthaler; Ulrich Hohenleutner 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract ## Background and Objective Presenting the long‐term results of flashlamp‐pumped pulsed dye laser treatment in 617 hemangiomas to evaluate this treatment modality. ## Study Design/Materials and Methods In 548 children, 692 hemangiomas were treated with the flashlamp‐pumped pulsed dye

Treatment of cutaneous hemangiomas in pr
Treatment of cutaneous hemangiomas in preterm neonatal twins with the flashlamp-pumped pulsed dye laser
✍ Ricci, Rita M.; Finley, Eric M.; Grimwood, Ronald E. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Background and Objective: We report two cases of hemangiomas in twins born at a gestational age of 30 weeks who were treated with a flashlamp-pumped pulsed dye laser (FPDL) at 40 days postpartem. These were the youngest patients to our knowledge to be treated with FPDL. Study Design/Patients an